<DOC>
	<DOCNO>NCT01179412</DOCNO>
	<brief_summary>The purpose study determine outcomes treat epidemic keratoconjunctivitis 2 % povidone-iodine .</brief_summary>
	<brief_title>Treatment Epidemic Keratoconjunctivitis With 2 % Povidone-iodine</brief_title>
	<detailed_description>The study design prospective interventional case series . Our institutional ethical committee approve study protocol April 2004 . We perform study July 2004 December 2009 . During period , 2 episode EKC epidemic . The first episode 2006 second 2009 .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Viral</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>patient diagnose EKC outpatient ophthalmic unit child young six year woman pregnant lactation history allergy povidoneiodine prior ocular surgery contact lens usage chronic eye diseases current eye medication .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>